mRNA |
etomoxir |
CTRPv2 |
pan-cancer |
AAC |
0.0087 |
0.8 |
mRNA |
GSK429286A |
GDSC1000 |
pan-cancer |
AAC |
0.0075 |
0.8 |
mRNA |
lenalidomide |
FIMM |
pan-cancer |
AAC |
-0.039 |
0.8 |
mRNA |
DBeQ |
CTRPv2 |
pan-cancer |
AAC |
-0.0082 |
0.8 |
mRNA |
Repligen 136 |
CTRPv2 |
pan-cancer |
AAC |
0.0083 |
0.8 |
mRNA |
Ko-143 |
CTRPv2 |
pan-cancer |
AAC |
0.0082 |
0.8 |
mRNA |
HG-5-88-01 |
GDSC1000 |
pan-cancer |
AAC |
0.01 |
0.8 |
mRNA |
selumetinib:MK-2206 (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.0078 |
0.8 |
mRNA |
dabrafenib |
GDSC1000 |
pan-cancer |
AAC |
-0.0066 |
0.8 |
mRNA |
navitoclax:sorafenib (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.0076 |
0.8 |